AI assistant
Sending…
Context Therapeutics Inc. — Director's Dealing 2025
Jun 12, 2025
34269_dirs_2025-06-12_7ae381f4-a8bd-4d31-a4dc-983d2f2af11e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Context Therapeutics Inc. (CNTX)
CIK: 0001842952
Period of Report: 2025-06-12
Reporting Person: West Linda (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-06-12 | Stock Option (right to buy) | $0.653 | A | 123500 | Acquired | 2035-06-11 | Common Stock (123500) | Direct |
Footnotes
F1: The option vests and becomes exercisable on the earlier of (i) June 12, 2026 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2026 annual meeting of stockholders, subject to continued service with the Issuer.
More from Context Therapeutics Inc.
Regulatory Filings
2026
May 18
Annual Report
2026
Apr 28
Regulatory Filings
2026
Apr 2
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Feb 27
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Feb 23
Major Shareholding Notification
2026
Feb 17